Screening for anti-NMDAR encephalitis in psychiatry

No Thumbnail Available
File version
Author(s)
Warren, N
Flavell, J
O'Gorman, C
Swayne, A
Blum, S
Kisely, S
Siskind, D
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2020
Size
File type(s)
Location
License
Abstract

Anti-NMDAR encephalitis most commonly presents to psychiatric services, so early identification of this disorder is essential. We aim to validate the two screening criteria (Scott et al. and Herken and Pruss) which have been proposed to identify first episode psychosis patients who should have anti-NMDAR antibody testing. The performance of the screening criteria were assessed using anti-NMDAR encephalitis cases published in the literature, and antibody positive and negative cases from a state-wide cohort (Queensland, Australia). Sensitivity, specificity and area under receiver operator characteristic curve analysis was performed. There were 258 anti-NMDAR encephalitis cases and 103 control cases, which demonstrated high performance of both Scott et al. “screening recommended” criteria (sensitivity 97.3%, specificity 85.4%, AUC 0.914) and Herken and Pruss “yellow flags” criteria (sensitivity 91.5%, specificity 83.5%, AUC 0.875). These criteria remained accurate when neurological variables were excluded, and in cases without psychosis. The Scott et al. “screening not recommended”, and Herken and Pruss “red flags” criteria did not demonstrate clinical utility for first episode psychosis case screening. The screening criteria with good performance identify an atypical picture of psychiatric presentation with increased risk of anti-NMDAR positivity prior to overt neurological symptoms or investigations and may be beneficial to include in the routine psychiatric assessment process.

Journal Title

Journal of Psychiatric Research

Conference Title
Book Title
Edition
Volume

125

Issue
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject

Biomedical and clinical sciences

Psychology

Anti-NMDAR

Autoimmune

Encephalitis

Psychosis

Screening

Persistent link to this record
Citation

Warren, N; Flavell, J; O'Gorman, C; Swayne, A; Blum, S; Kisely, S; Siskind, D, Screening for anti-NMDAR encephalitis in psychiatry, Journal of Psychiatric Research, 2020, 125, pp. 28-32

Collections